Reframe Daily: New pill stops menopause hot flashes without hormones—FDA approved this week

Reframe Daily—curated by Christin Chong (neuroscience PhD, Buddhist chaplain, healthtech strategy consultant)—delivers optimistic and credible healthtech updates you won’t find in most popular news outlets, from sources scientists and healthcare providers read and trust.

Today in one sentence: The FDA approved the first hormone-free pill for menopause symptoms and a targeted leukemia treatment; a microchip eye implant helped legally blind patients read again; doctors found that testing grip strength can predict who will stay healthy despite carrying extra weight; and a new antibody drug significantly reduced painful dryness and fatigue in people with Sjögren's autoimmune disease.

Pop in the Discord to chat about health →
https://forms.gle/tN3oabFTsDF21VnS8

Personal shares from Christin here →
http://christin.substack.com/

Good news: A simple pill can now stop menopause hot flashes without hormones, helping millions of women who can't or don't want to use traditional hormone therapy.
Bayer's Lynkuet (elinzanetant) Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause
Market readiness: 🙂🙂🙂🙂🙂 (FDA approved October 24, 2025; available in US starting November 2025)

Good news: A new cancer drug was approved that specifically targets a gene mutation in leukemia, giving patients a pill treatment option when other therapies stop working.
FDA Approves Revumenib for Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible NPM1 Mutation
Market readiness: 🙂🙂🙂🙂🙂 (FDA approved October 24, 2025)

Good news: A tiny implant smaller than a pinhead can help blind people with macular degeneration see well enough to read letters and words again.
Vision Restoration with the PRIMA System in Geographic Atrophy Due to AMD
Market readiness: 🙂🙂🙂🙂 (Clinical trial complete with published results in NEJM; European regulatory approval application submitted, may be available in Europe early 2026)

Good news: A new medicine significantly reduced symptoms of Sjögren's disease, an autoimmune condition that causes painful dryness throughout the body and affects millions of people.
Efficacy and Safety of Nipocalimab in Patients with Moderate-to-Severe Sjögren's Disease
Market readiness: 🙂🙂🙂 (Phase 2 completed successfully, Phase 3 trial currently enrolling patients; has FDA Breakthrough Therapy designation)

Good news: Scientists discovered that having stronger muscles and grip strength protects people with excess body fat from developing serious health problems like heart disease and organ damage.
Handgrip Strength and Trajectories of Preclinical Obesity Progression: A Multistate Model Analysis Using the UK Biobank
Market readiness: 🙂🙂 (Published research showing grip strength testing can identify at-risk individuals; grip strength tests are already available but this finding needs validation before being adopted as standard clinical practice for obesity screening)

Thank you for taking the time to take care of yourself and your loved ones.